Abstract
The author examines some dilemmas raised by the increasing use of clomipramine in the treatment of obsessional disorders. He presents a case vignette to illustrate some diagnostic, therapeutic and ethical concerns and suggests that by asking certain questions, pitfalls can be avoided.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Australian and New Zealand journal of psychiatry
Paper Title
Journal
Date
